Pharmacists in Satsuma, AL Accepting Medicare
6 Pharmacists found. Showing 1 - 6
 Mr. Byron Hughes Howell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5565 Hwy 43, Satsuma, AL 36572 Phone: 251-675-2070 Fax: 251-675-7785 |
 Caye Margaret Mcconaghy, RPH, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5565 Hwy 43, Satsuma, AL 36572 Phone: 251-675-2070 Fax: 251-675-7785 |
Mr. Wilbur Embree Price, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5565 Hwy 43, Satsuma, AL 36572 Phone: 251-675-2070 Fax: 251-675-7785 |
Mr. Brightman Blonzo Coker Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5565 Hwy 43, Satsuma, AL 36572 Phone: 251-675-2070 Fax: 251-675-7785 |
Jillian Blair Thomas, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5567 Highway 43, Satsuma, AL 36572 Phone: 257-675-3228 |
Aubrey Bryan Higdon, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5565 Hwy 43, Satsuma, AL 36572 Phone: 251-675-2070 |
News Archive
Dog-interaction activities improve mood among teenagers living in treatment centers
Lindsay Ellsworth is prescribing a new, mood-boosting therapy for teenagers in drug and alcohol treatment: shelter dogs. On Friday afternoons, about four dogs from the Spokane Humane Society take a field trip to Excelsior Youth Center as a group of teenage boys eagerly await their arrival. Ellsworth, a doctoral candidate in animal sciences at Washington State University, organizes the meet-ups where participants can help brush, feed and play with the dogs.
Chiropractic treatment could lead to vision problems
For those in the habit of getting their neck adjusted by a chiropractor, the University of Michigan Kellogg Eye Center has interesting information to know about: High velocity neck manipulation has been shown to result in stress on the eye and lead to spotty vision.
Committees will weigh up COX-2 benefits and risks
The U.S. Food and Drug Administration (FDA) has announced a joint public meeting of the agency's Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee to be held February 16, 17 and 18, 2005.
FDA approves new therapy for initial treatment of soft tissue sarcoma
The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS), which are cancers that develop in muscles, fat, tendons or other soft tissues.
› Verified 5 days ago